πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda β€” grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≀24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months β€” use filters for patent-cliff planning.

Page 23 of 30

  1. US 7517910

    Alkoxyphenylpropanoic acid derivatives

    Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7514441

    Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7510728

    Solid preparations

    Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7507740

    Fused heterocyclic compound

    Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7507753

    Biaryl compound and use thereof

    Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7507841

    Cannabinoid receptor modulator

    Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7498337

    Acid secretion inhibitor

    Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7498352

    TGF-Ξ² superfamily production/secretion promoter

    Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7495018

    Substituted 1,3-thiazole compounds, their production and use

    Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7491802

    Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer

    Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7479484

    Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity

    Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7476657

    Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments

    Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7470700

    Dipeptidyl peptidase inhibitors

    Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7465815

    Cannabinoid receptor modulator

    Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7462635

    Thiazole and oxazole VDAC regulator

    Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7462628

    Preventives/remedies for urinary disturbance

    Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7456162

    Benzofuran derivatives, their production and use

    Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7445890

    Ucp-2 promoter and use thereof

    Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7431942

    Orally disintegrable tablets

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7429559

    Controlled release composition and method of producing the same

    Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7423159

    Agent for preventing or treating neuropathy

    Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7419973

    Phosphonocephem compound

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7419956

    Isolated physiologically active peptide and use thereof

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7417059

    Substituted aromatic-ring compounds, process for producing the same and use

    Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7410641

    Antibodies to insulin/IGF/relaxin family polypeptides

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7410776

    Polypeptides, their production and use

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7410981

    Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7402595

    JNK inhibitor

    Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7399485

    Rapidly Disintegrable solid preparation

    Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7399759

    1, 3-benzothiazinone derivatives and use thereof

    Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7396841

    Injections

    Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7396848

    Neurotrophin production/secretion promoting agent

    Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7390625

    Apoptosis-associated protein and use thereof

    Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7388032

    Sustained release compositions, process for producing the same and utilization thereof

    Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7381825

    Histone deacetylase inhibitors

    Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7378108

    Percutaneous absorption preparation of compound having angiotensin II antagonistic activity

    Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7375074

    Body weight gain inhibitor

    Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7374910

    DNA encoding galanin receptor activating peptide

    Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7375228

    Histone deacetylase inhibitors

    Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7371772

    Bicyclic compound, production and use thereof

    Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7368578

    Five-membered heterocyclic compounds

    Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7355001

    Organic anion transport protein TCH229

    Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7348324

    Cyclic amine compounds as CCR5 antagonists

    Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7342105

    Antibody and use thereof

    Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7339064

    Benzimidazole compound crystal

    Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7323541

    Polypeptide DNA thereof and use of the same

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7314754

    Polynucleotide encoding the hOT7T175 G protein coupled receptor

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7309693

    Preventives and remedies for pulmonary hypertension

    Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.